The US Supreme Court unanimously backed Thermo Fisher Scientific Inc. subsidiary Life Technologies Corp. on Feb. 22, ruling that Life Technologies hadn’t violated a DNA test-kit patent held by Promega Corp.
The 7-0 decision overturns a 2014 decision by the Federal Circuit Court of Appeals.
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?